USANA Health Sciences Inc... (USNA)
USANA Health Sciences Statistics
Share Statistics
USANA Health Sciences has 18.9M shares outstanding. The number of shares has increased by -0.77% in one year.
Shares Outstanding | 18.9M |
Shares Change (YoY) | -0.77% |
Shares Change (QoQ) | -0.81% |
Owned by Institutions (%) | 56.51% |
Shares Floating | 11.12M |
Failed to Deliver (FTD) Shares | 10 |
FTD / Avg. Volume | 0.01% |
Short Selling Information
The latest short interest is 485.88K, so 2.55% of the outstanding shares have been sold short.
Short Interest | 485.88K |
Short % of Shares Out | 2.55% |
Short % of Float | 4.33% |
Short Ratio (days to cover) | 3.57 |
Valuation Ratios
The PE ratio is undefined and the forward PE ratio is 11.44. USANA Health Sciences's PEG ratio is undefined.
PE Ratio | undefined |
Forward PE | 11.44 |
PS Ratio | 0.8 |
Forward PS | 0.5 |
PB Ratio | 1.28 |
P/FCF Ratio | undefined |
PEG Ratio | undefined |
Enterprise Valuation
USANA Health Sciences Inc. has an Enterprise Value (EV) of 714.59M.
EV / Earnings | 17 |
EV / Sales | 0.84 |
EV / EBITDA | 7.23 |
EV / EBIT | 10.77 |
EV / FCF | 14.03 |
Financial Position
The company has a current ratio of 2, with a Debt / Equity ratio of undefined.
Current Ratio | 2 |
Quick Ratio | 1.5 |
Debt / Equity | undefined |
Total Debt / Capitalization | 4.14 |
Cash Flow / Debt | 2.65 |
Interest Coverage | undefined |
Financial Efficiency
Return on equity (ROE) is 0.08% and return on capital (ROIC) is 5.99%.
Return on Equity (ROE) | 0.08% |
Return on Assets (ROA) | 0.06% |
Return on Capital (ROIC) | 5.99% |
Revenue Per Employee | $502,648.82 |
Profits Per Employee | $24,723.53 |
Employee Count | 1,700 |
Asset Turnover | 1.14 |
Inventory Turnover | 2.31 |
Taxes
Income Tax | 34.32M |
Effective Tax Rate | 0.45 |
Stock Price Statistics
The stock price has increased by -43.68% in the last 52 weeks. The beta is 0.98, so USANA Health Sciences's price volatility has been higher than the market average.
Beta | 0.98 |
52-Week Price Change | -43.68% |
50-Day Moving Average | 31.05 |
200-Day Moving Average | 37.34 |
Relative Strength Index (RSI) | 37.11 |
Average Volume (20 Days) | 193.53K |
Income Statement
In the last 12 months, USANA Health Sciences had revenue of 854.5M and earned 42.03M in profits. Earnings per share was 2.2.
Revenue | 854.5M |
Gross Profit | 693.29M |
Operating Income | 66.32M |
Net Income | 42.03M |
EBITDA | 98.86M |
EBIT | 66.32M |
Earnings Per Share (EPS) | 2.2 |
Balance Sheet
The company has 181.77M in cash and 23M in debt, giving a net cash position of 158.77M.
Cash & Cash Equivalents | 181.77M |
Total Debt | 23M |
Net Cash | 158.77M |
Retained Earnings | 478.94M |
Total Assets | 748.19M |
Working Capital | 139.56M |
Cash Flow
In the last 12 months, operating cash flow was 60.99M and capital expenditures -10.07M, giving a free cash flow of 50.92M.
Operating Cash Flow | 60.99M |
Capital Expenditures | -10.07M |
Free Cash Flow | 50.92M |
FCF Per Share | 2.67 |
Margins
Gross margin is 81.13%, with operating and profit margins of 7.76% and 4.92%.
Gross Margin | 81.13% |
Operating Margin | 7.76% |
Pretax Margin | 8.94% |
Profit Margin | 4.92% |
EBITDA Margin | 11.57% |
EBIT Margin | 7.76% |
FCF Margin | 5.96% |
Dividends & Yields
USNA does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Payout Ratio | n/a |
Earnings Yield | 8.15% |
FCF Yield | 9.97% |
Analyst Forecast
The average price target for USNA is $36, which is 33.3% higher than the current price. The consensus rating is "Hold".
Price Target | $36 |
Price Target Difference | 33.3% |
Analyst Consensus | Hold |
Analyst Count | 1 |
Stock Splits
The last stock split was on Nov 23, 2016. It was a forward split with a ratio of 2:1.
Last Split Date | Nov 23, 2016 |
Split Type | forward |
Split Ratio | 2:1 |
Scores
Altman Z-Score | 4.53 |
Piotroski F-Score | 6 |